• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗体介导的肾移植排斥反应的治疗反应与监测]

[Therapeutic response and monitoring of antibody-mediated renal graft rejection].

作者信息

Hurtado-Castillo Yumar Alfredo, Serrano-Ramírez Juana Alejandra, Juaréz-Sánchez José Oscar, Gaytán-Campos Itzy Maely

机构信息

Instituto Mexicano del Seguro Social, Centro Médico Nacional del Bajío, Hospital de Especialidades No. 1, Servicio de Nefrología. León, Guanajuato, México.

出版信息

Rev Med Inst Mex Seguro Soc. 2025 May 2;63(3):e6636. doi: 10.5281/zenodo.15178468.

DOI:10.5281/zenodo.15178468
PMID:40332680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12122064/
Abstract

BACKGROUND

Antibody-mediated renal graft rejection is one of the main causes of graft loss. Treatment is based on the removal of circulating antibodies, inhibition of residual antibodies, reduction of their formation, minimization of the alloresponse and terminal complement activation.

OBJECTIVE

To assess the therapeutic response in patients who received intravenous immunoglobulin, plasmapheresis, steroid and rituximab as treatment for antibody-mediated renal rejection.

MATERIAL AND METHODS

An applicative, prospective study was carried out in hospitalized patients under the care of a nephrology service with a diagnosis of antibody-mediated rejection of the renal graft according to BANFF. 20 patients were included in 1 year, the biopsy was reviewed in an effort to classify the type of antibody-mediated rejection and the response to treatment was evaluated to demonstrate whether there was stabilization or improvement in renal function at 12 months of follow-up.

RESULTS

Using the Wilcoxon test, creatinine during the biopsy of the injected and creatinine 12 months after receiving the therapeutic regimen were compared. The Z value was -1.8, with a p = 0.069.

CONCLUSIONS

There was no difference in terms of stabilization or recovery of renal graft function after 12 months of receiving treatment for antibody-mediated rejection based on steroids, plasma exchanges, immunoglobulin and rituximab.

摘要

背景

抗体介导的肾移植排斥反应是移植肾丢失的主要原因之一。治疗基于清除循环抗体、抑制残留抗体、减少其形成、使同种异体反应最小化以及终末补体激活。

目的

评估接受静脉注射免疫球蛋白、血浆置换、类固醇和利妥昔单抗治疗抗体介导的肾排斥反应患者的治疗反应。

材料与方法

对肾脏病服务部门护理下的住院患者进行了一项应用前瞻性研究,这些患者根据班夫标准诊断为抗体介导的肾移植排斥反应。1年内纳入20例患者,对活检进行复查以对抗体介导的排斥反应类型进行分类,并评估治疗反应以证明在随访12个月时肾功能是否稳定或改善。

结果

使用威尔科克森检验比较了注射时活检时的肌酐水平与接受治疗方案12个月后的肌酐水平。Z值为-1.8,p = 0.069。

结论

在接受基于类固醇、血浆置换、免疫球蛋白和利妥昔单抗的抗体介导排斥反应治疗12个月后,移植肾功能的稳定或恢复方面没有差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ff/12122064/403fa43ba459/04435117-63-3-6636-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ff/12122064/403fa43ba459/04435117-63-3-6636-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ff/12122064/403fa43ba459/04435117-63-3-6636-f001.jpg

相似文献

1
[Therapeutic response and monitoring of antibody-mediated renal graft rejection].[抗体介导的肾移植排斥反应的治疗反应与监测]
Rev Med Inst Mex Seguro Soc. 2025 May 2;63(3):e6636. doi: 10.5281/zenodo.15178468.
2
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.使用抗胸腺细胞球蛋白(ATG)单药治疗以及利妥昔单抗、静脉注射免疫球蛋白和血浆置换联合治疗活检证实的急性抗体介导排斥反应:从初步经验中获得的教训
Clin Transpl. 2014:223-30.
3
Antibody-mediated rejection and treatment in pediatric patients: one center's experience.儿童患者的抗体介导性排斥反应及治疗:一个中心的经验
Exp Clin Transplant. 2013 Oct;11(5):404-7. doi: 10.6002/ect.2012.0242.
4
Acute antibody-mediated rejection in paediatric renal transplant recipients.儿童肾移植受者的急性抗体介导的排斥反应。
Pediatr Nephrol. 2011 Jul;26(7):1149-56. doi: 10.1007/s00467-011-1864-3. Epub 2011 Apr 1.
5
Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients: Single-Center Experience.肾移植受者慢性活动性抗体介导排斥反应的管理:单中心经验
Exp Clin Transplant. 2019 Jan;17(Suppl 1):113-119. doi: 10.6002/ect.MESOT2018.O58.
6
Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.强化血浆置换和静脉注射免疫球蛋白治疗肾移植后抗体介导的排斥反应。
Exp Clin Transplant. 2014 Aug;12(4):328-33.
7
Treatment of acute antibody-mediated rejection: a single-center experience.急性抗体介导排斥反应的治疗:单中心经验
Transplant Proc. 2010 Oct;42(8):2848-50. doi: 10.1016/j.transproceed.2010.07.068.
8
Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.基于2013年班夫标准的肾移植急性抗体介导排斥反应:乌拉圭单中心经验
Transplant Proc. 2016 Mar;48(2):612-5. doi: 10.1016/j.transproceed.2016.03.019.
9
Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.肾移植中晚期抗体介导的排斥反应:传统疗法与新疗法后的结局
Transplantation. 2014 Jun 27;97(12):1240-6. doi: 10.1097/01.TP.0000442503.85766.91.
10
Late acute antibody mediated rejection after nine years of renal transplantation.肾移植九年之后发生的迟发性急性抗体介导排斥反应。
Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1111-4.

本文引用的文献

1
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).在一项前瞻性、多中心、非选择性队列研究(EU-TRAIN)中评估肾移植排斥的非侵入性生物标志物。
Kidney Int. 2024 Nov;106(5):943-960. doi: 10.1016/j.kint.2024.07.027. Epub 2024 Aug 27.
2
Effect of Hydroxychloroquine Treatment on Kidney Allograft Rejection and Graft Failure.羟氯喹治疗对肾移植排斥和移植物失功的影响。
Transplant Proc. 2024 Jul-Aug;56(6):1251-1258. doi: 10.1016/j.transproceed.2024.05.027. Epub 2024 Jul 11.
3
Current Therapies in Kidney Transplant Rejection.
肾移植排斥反应的当前治疗方法
J Clin Med. 2023 Jul 27;12(15):4927. doi: 10.3390/jcm12154927.
4
Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.移植肾管理面临的挑战:从下降到衰竭:KDIGO 争议会议的结论。
Kidney Int. 2023 Dec;104(6):1076-1091. doi: 10.1016/j.kint.2023.05.010. Epub 2023 May 24.
5
An automated histological classification system for precision diagnostics of kidney allografts.一种用于肾移植精准诊断的自动化组织学分类系统。
Nat Med. 2023 May;29(5):1211-1220. doi: 10.1038/s41591-023-02323-6. Epub 2023 May 4.
6
Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection.免疫修饰纳米颗粒靶向炎症性单核细胞可预防急性肾移植排斥反应。
Kidney Int. 2022 Nov;102(5):1090-1102. doi: 10.1016/j.kint.2022.06.024. Epub 2022 Jul 16.
7
Alloimmune Risk Stratification for Kidney Transplant Rejection.同种免疫风险分层在肾移植排斥反应中的应用
Transpl Int. 2022 May 20;35:10138. doi: 10.3389/ti.2022.10138. eCollection 2022.
8
Risk Factors of Rejection in Renal Transplant Recipients: A Narrative Review.肾移植受者排斥反应的危险因素:一项叙述性综述
J Clin Med. 2022 Mar 3;11(5):1392. doi: 10.3390/jcm11051392.
9
Allorecognition and the spectrum of kidney transplant rejection.同种异体识别与肾移植排斥反应谱
Kidney Int. 2022 Apr;101(4):692-710. doi: 10.1016/j.kint.2021.11.029. Epub 2021 Dec 13.
10
A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.促进药物依从性以降低晚期肾移植排斥反应:一项质量改进研究。
Am J Kidney Dis. 2022 Mar;79(3):335-346. doi: 10.1053/j.ajkd.2021.06.021. Epub 2021 Aug 3.